Compare Denison Mines Corp Ordinary Shares (Canada) (DNN) vs Johnson & Johnson (JNJ) Price & Performance

Denison Mines Corp Ordinary Shares (Canada)Trade

Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Denison Mines Corp Ordinary Shares (Canada) vs Johnson & Johnson — how do they compare? Denison Mines Corp Ordinary Shares (Canada) trades at $2.41 (market cap $2.14B), while Johnson & Johnson trades at $256.82 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 288.8× Denison Mines Corp Ordinary Shares (Canada)'s market cap, and Johnson & Johnson pays a 2.09% dividend while Denison Mines Corp Ordinary Shares (Canada) pays none. Which is the better fit depends on your goals — on Pluang, investors hold Denison Mines Corp Ordinary Shares (Canada) for 0 Days and Johnson & Johnson for 129 Days on average.

	DNN	JNJ
Market Cap	$2.14B	$618.09B
Volume	56,727,592	6,050,983
Sector	Energy	Health
52-Week High	$4.37	$278.43
52-Week Low	$2.27	$186.00
Typical Hold Time	0 Days	129 Days
Enterprise Value	$1.98B	$646.37B
Dividend Yield	—	2.09%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Denison Mines Corp Ordinary Shares (Canada)

No Aura AI signal available yet.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.

JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNN

100% Buy0% Sell

Avg holding period · 0 Days

JNJ

96% Buy4% Sell

Avg holding period · 129 Days

Top news

Latest headlines on both assets

DNN

View details →

JNJ

Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growthGordon Thompson · 2 hours agoNeutral Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.24/7 Wall Street · 5 hours agoNeutral New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.PRNewsWire · 6 hours agoBullish View details →

About Denison Mines Corp Ordinary Shares (Canada)

Denison Mines is a uranium mining, development, and exploration company focused on Canada's Athabasca Basin. Its portfolio includes the Wheeler River project and interests in other uranium projects and processing facilities.

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.